Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Waidyanatha, S.
Right arrow Articles by Rappaport, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waidyanatha, S.
Right arrow Articles by Rappaport, S. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 2, 279-286, February 2001
© 2001 Oxford University Press


CARCINOGENESIS

Urinary benzene as a biomarker of exposure among occupationally exposed and unexposed subjects

Suramya Waidyanatha, Nathaniel Rothman1, Silvia Fustinoni2, Martyn T. Smith3, Richard B. Hayes1, William Bechtold4, Mustafa Dosemeci1, Li Guilan5, Songnian Yin5 and Stephen M. Rappaport6

Department of Environmental Sciences and Engineering, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7400, USA,
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA,
2 Istituti Clinici di Perfezionamento, Via S.Barnaba 8, I-20122 Milan, Italy,
3 School of Public Health, University of California at Berkeley, Berkeley, CA 94720, USA,
4 Lovelace Respiratory Research Institute, PO Box 5890, Albuquerque, NM 87185, USA and
5 Chinese Academy of Preventive Medicine, Institute of Occupational Medicine, Beijing, China

Urinary benzene (UB) was investigated as a biomarker of exposure among benzene-exposed workers and unexposed subjects in Shanghai, China. Measurements were performed via headspace solid phase microextraction of 0.5 ml of urine specimens followed by gas chromatography–mass spectrometry. This assay is simple and more sensitive than other methods (detection limit 0.016 µg benzene/l urine). The median daily benzene exposure was 31 p.p.m. (range 1.65–329 p.p.m.). When subjects were divided into controls (n = 41), those exposed to <=31 p.p.m. benzene (n = 22) and >31 p.p.m. benzene (n = 20), the median UB levels were 0.069, 4.95 and 46.1 µg/l, respectively (Spearman r = 0.879, P < 0.0001). A linear relationship was observed between the logarithm of UB and the logarithm of benzene exposure in exposed subjects according to the following equation: ln(UB, µg/l) = 0.196 + 0.709 ln (exposure, p.p.m.) (r = 0.717, P < 0.0001). Considering all subjects, linear relationships were also observed between the logarithm of UB and the corresponding logarithms of four urinary metabolites of benzene, namely t,t-muconic acid (r = 0.938, P < 0.0001), phenol (r = 0.826, P < 0.0001), catechol (r = 0.812, P < 0.0001) and hydroquinone (r = 0.898, P < 0.0001). Ratios of individual metabolite levels to total metabolites versus UB provide evidence of competitive inhibition of CYP450 enzymes leading to increased production of phenol and catechol at the expense of hydroquinone and muconic acid. Among control subjects UB was readily detected with a mean level of 0.145 µg/l (range 0.027–2.06 µg/l), compared with 5.63 µg/l (range 0.837–26.38 µg/l) in workers exposed to benzene below 10 p.p.m. (P < 0.0001). This suggests that UB is a good biomarker for exposure to low levels of benzene.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
S Wilbur, D Wohlers, S Paikoff, L. Keith, and O Faroon
ATSDR evaluation of health effects of benzene and relevance to public health
Toxicology and Industrial Health, June 1, 2008; 24(5-6): 263 - 398.
[Abstract] [PDF]


Home page
Toxicol Ind HealthHome page
S. Suna, T. Hirao, F. Asakawa, T. Suzue, T. Mannami, and F. Jitsunari
Possible sources of urinary benzene among nonoccupationally exposed Japanese subjects
Toxicology and Industrial Health, April 1, 2008; 24(3): 155 - 160.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Kim, R. Vermeulen, S. Waidyanatha, B. A. Johnson, Q. Lan, M. T. Smith, L. Zhang, G. Li, M. Shen, S. Yin, et al.
Modeling Human Metabolism of Benzene Following Occupational and Environmental Exposures.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2246 - 2252.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Kim, R. Vermeulen, S. Waidyanatha, B. A. Johnson, Q. Lan, N. Rothman, M. T. Smith, L. Zhang, G. Li, M. Shen, et al.
Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism
Carcinogenesis, April 1, 2006; 27(4): 772 - 781.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Fustinoni, D. Consonni, L. Campo, M. Buratti, A. Colombi, A. C. Pesatori, M. Bonzini, P. A. Bertazzi, V. Foa, S. Garte, et al.
Monitoring Low Benzene Exposure: Comparative Evaluation of Urinary Biomarkers, Influence of Cigarette Smoking, and Genetic Polymorphisms
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2237 - 2244.
[Abstract] [Full Text] [PDF]


Home page
ANN OCCUP HYGHome page
P. P. EGEGHY, L. NYLANDER-FRENCH, K. K. GWIN, I. HERTZ-PICCIOTTO, and S. M. RAPPAPORT
Self-collected Breath Sampling for Monitoring Low-level Benzene Exposures among Automobile Mechanics
Ann. Hyg., July 1, 2002; 46(5): 489 - 500.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Yeowell-O'Connell, N. Rothman, S. Waidyanatha, M. T. Smith, R. B. Hayes, G. Li, W. E. Bechtold, M. Dosemeci, L. Zhang, S. Yin, et al.
Protein Adducts of 1,4-Benzoquinone and Benzene Oxide among Smokers and Nonsmokers Exposed to Benzene in China
Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 831 - 838.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.